Jazz Pharmaceuticals Plc (JAZZ)
161.13
+0.88
(+0.55%)
USD |
NASDAQ |
Jan 09, 16:00
161.29
+0.16
(+0.10%)
After-Hours: 20:00
Jazz Pharmaceuticals Research and Development Expense (Annual): 884.00M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Zymeworks, Inc. | 134.62M |
| Alkermes Plc | 239.63M |
| Medtronic Plc | 2.732B |
| Avadel Pharmaceuticals Plc | 15.20M |
| Amarin Corp. Plc | 17.86M |